Abstract:This paper reports a biocompatible and label-free cell separation method using ferrofluids that can separate a variety of low-concentration cancer cells from cell culture lines (similar to 100 cancer cells per mL) from undiluted white blood cells, with a throughput of 1.2 mL h(-1) and an average separation efficiency of 82.2%. The separation is based on the size difference of the cancer cells and white blood cells, and is conducted in a custom-made biocompatible ferrofluid that retains not only excellent short-term viabilities but also normal proliferations of 7 commonly used cancer cell lines. A microfluidic device is designed and optimized specifically to shorten the time of live cells' exposure to ferrofluids from hours to seconds, by eliminating time-consuming off-chip sample preparation and extraction steps and integrating them on-chip to achieve a one-step process. As a proof-of-concept demonstration, a ferrofluid with 0.26% volume fraction was used in this microfluidic device to separate spiked cancer cells from cell lines at a concentration of similar to 100 cells per mL from white blood cells with a throughput of 1.2 mL h(-1). The separation efficiencies were 80 +/- 3%, 81 +/- 5%, 82 +/- 5%, 82 +/- 4%, and 86 +/- 6% for A549 lung cancer, H1299 lung cancer, MCF-7 breast cancer, MDA-MB-231 breast cancer, and PC-3 prostate cancer cell lines, respectively. The separated cancer cells' purity was between 25.3% and 28.8%. In addition, the separated cancer cells from this strategy showed an average short-term viability of 94.4 +/- 1.3%, and these separated cells were cultured and demonstrated normal proliferation to confluence even after the separation process. Owing to its excellent biocompatibility and label-free operation and its ability to recover low concentrations of cancer cells from white blood cells, this method could lead to a promising tool for rare cell separation.

Biocompatible and label-free separation of cancer cells from cell culture lines from white blood cells in ferrofluids

Label-free cancer cell separation from whole blood on centrifugal microfluidic platform using hydrodynamic technique

Efficient Separation of Tumor Cells from Untreated Whole Blood Using a Novel Multistage Hydrodynamic Focusing Microfluidics.

Isolation of leukemia and breast cancer cells from liquid biopsies and clinical samples at low concentration in a 3D printed cell separation device via transferrin-receptor affinity

Deformability and size-based cancer cell separation using an integrated microfluidic device

Dielectrophoretic Separation of Prostate Cancer Cells

High-throughput rare cell separation from blood samples using steric hindrance and inertial microfluidics.

Low‐cost Polymer‐film Spiral Inertial Microfluidic Device for Label‐free Separation of Malignant Tumor Cells

Label-free Separation of Circulating Tumor Cells Using a Self-Amplified Inertial Focusing (SAIF) Microfluidic Chip.

Microfluidic-based cancer cell separation using active and passive mechanisms

Label-free single-cell separation and imaging of cancer cells using an integrated microfluidic system

Size-amplified Acoustofluidic Separation of Circulating Tumor Cells with Removable Microbeads

Enhancing cell separation in a hybrid spiral dielectrophoretic microchannel: Numerical insights and optimal operating conditions

Automated Microfluidic Instrument for Label-Free and High-Throughput Cell Separation

A high-throughput liquid biopsy for rapid rare cell separation from large-volume samples

The Label-Free Separation and Culture of Tumor Cells in a Microfluidic Biochip

Hybrid double-spiral microfluidic chip for RBC-lysis-free enrichment of rare cells from whole blood

Antibody conjugated magnetic iron oxide nanoparticles for cancer cell separation in fresh whole blood.

High-throughput and simultaneous inertial separation of tumor cells and clusters from malignant effusions using spiral-contraction-expansion channels

A Combined Negative and Positive Enrichment Assay for Cancer Cells Isolation and Purification.

Noninvasive Optical Isolation and Identification of Circulating Tumor Cells Engineered by Fluorescent Microspheres